141P Early phase trials outcomes in refractory upper GI cancers: A 10-year analysis from the SCRI UK phase I unit
Cammarota, A., Turgeman, I., Aghayeva, F., Woodford, R., Grochot, R.M., Choy, J., De Burgh Williams, A., Arkenau, H-T., Fontana, E.
Published in Annals of oncology (01.11.2023)
Published in Annals of oncology (01.11.2023)
Get full text
Journal Article
121P ATM germline mutations in lethal prostate cancer
Grochot, R.M., Carreira, S., Miranda, S., Figueiredo, I., Bertan, C., Rekowski, J., Yuan, W., Ferreira, A., Riisnaes, R., Neeb, A., Gurel, B., Fenor de la Maza, M.D.L.D., Carmichael, J., Westaby, D., Guo, C., Sharp, A., de Bono, J.S.
Published in Annals of oncology (01.10.2022)
Published in Annals of oncology (01.10.2022)
Get full text
Journal Article
63P Activity and safety of FGFR inhibitors in pan-cancer patients with FGF/FGFR alterations and advanced malignancies: A pooled analysis of 7 phase I/II trials
Grochot, R.M., Joshi, K., Sathanantham, G., Cammarota, A., Woodford, R., De Burgh Williams, A., Arkenau, H-T., Subbiah, V., Fontana, E.
Published in ESMO open (01.02.2024)
Published in ESMO open (01.02.2024)
Get full text
Journal Article